55 related articles for article (PubMed ID: 20577949)
21. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
22. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Maione P; Rossi A; Di Maio M; Gridelli C
Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
[TBL] [Abstract][Full Text] [Related]
23. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
25. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
[TBL] [Abstract][Full Text] [Related]
26. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
27. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
28. Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
Di Maio M; Lama N; Morabito A; Smit EF; Georgoulias V; Takeda K; Quoix E; Hatzidaki D; Wachters FM; Gebbia V; Tsai CM; Camps C; Schuette W; Chiodini P; Piccirillo MC; Perrone F; Gallo C; Gridelli C
Eur J Cancer; 2010 Mar; 46(4):735-43. PubMed ID: 20045311
[TBL] [Abstract][Full Text] [Related]
29. Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.
Chen YM; Chao JY; Tsai CM; Shiau CY; Liang MJ; Yen SH; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):459-66. PubMed ID: 10925536
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
31. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
He JJ; Zhi K; Liu GF
Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
[TBL] [Abstract][Full Text] [Related]
33. Perceptions of health status and survival in patients with metastatic lung cancer.
Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Gallagher ER; Prigerson HG; Temel JS
J Pain Symptom Manage; 2014 Oct; 48(4):548-57. PubMed ID: 24680623
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores.
Gironés R; Torregrosa D; Gómez-Codina J; Maestu I; Tenias JM; Rosell R
Lung Cancer; 2011 Apr; 72(1):108-13. PubMed ID: 20727613
[TBL] [Abstract][Full Text] [Related]
35. Preoperative examination to detect distant metastasis is not advocated for asymptomatic patients with stages 1 and 2 non-small cell lung cancer. Preoperative examination for lung cancer.
Ichinose Y; Hara N; Ohta M; Motohiro A; Maeda T; Nobe T; Yagawa K
Chest; 1989 Nov; 96(5):1104-9. PubMed ID: 2553343
[TBL] [Abstract][Full Text] [Related]
36. Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit.
Hobbins S; West D; Peake M; Beckett P; Woolhouse I
BMJ Open; 2016 Sep; 6(9):e012530. PubMed ID: 27678543
[TBL] [Abstract][Full Text] [Related]
37. Decision analysis in NSCLC.
Macbeth F
Thorax; 2002 Oct; 57(10):919-20; author reply 920. PubMed ID: 12324684
[No Abstract] [Full Text] [Related]
38. Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up.
Baak JPA; Li H; Guo H
Front Oncol; 2022; 12():837419. PubMed ID: 35186767
[TBL] [Abstract][Full Text] [Related]
39. Stage IV lung cancer: the relevance of tumour profile for the construction of prognostic groups.
Rami-Porta R; Fong KM
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36731903
[No Abstract] [Full Text] [Related]
40. (S036) Circulating Tumor DNA and Implications for Clinical Decision-Making in Stage I NSCLC.
Oncology (Williston Park); 2015 Apr; 29(4 Suppl 1):. PubMed ID: 25930748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
